explore -WSS

explore

author：knowledge 2025-09-30 14:09:50 - browse：56

In a lab at Harvard Medical School, Professor David A. Sinclair looks into the camera from behind a row of bottles — coverage from STAT — David Sinclair in his lab at Harvard Medical School. Craig F. Walker/Globe Staff

Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists had developed the first pill — well, a soft, beef-flavored chew — “proven to reverse aging” in dogs. Which miracle molecules delivered this supposed scientific breakthrough, he didn’t say. But he told his 438,000 followers on X where they could buy it: the website of Animal Bioscience, a veterinary supplement company he founded and which is headed by his brother, Nick Sinclair.

The claim in a company news release, followed by the tweet stating that the supplement was “proven to slow the effects of aging,” has sparked outrage from other scientists online, and the board of an international organization of top longevity researchers — which David Sinclair leads — will discuss the matter at its meeting this week.

Despite his enthusiasm, there is no published scientific research that has yet demonstrated the compounds in Animal Bioscience’s supplements — which have been on the market for more than a year — reverse or even slow aging in dogs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Wearables generate powerful data but its not useful to doctors, yet

explore

WSS

Venture capitalist Bob Kocher on the state of digital health

Microsoft strikes partnership with Duke Health to advance health AI

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

HIV vaccine remains elusive. Immunologists keep trying new ideas

Arc Institute generative AI designs new CRISPR systems

TytoCare raises $49 million to build out AI

hotspot

explore

explore

Alkermes shareholders re

Venture capitalist Bob Kocher on the state of digital health

What does generative AI mean for health care? We asked experts

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Medical leaders decry Supreme Court decision on affirmative action

NVIDIA and Google execs on the future of AI and drug discovery

Drug repurposing or repositioning? The language matters

Case highlights the risks of experimental stem cell therapy

Wikipedia

Addiction experts warn against a second 'war on drugs'

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

What the cancer research community can learn from the Covid response

Military medical care influenced by rank and race, new study finds

Cytokinetics CEO stresses company can launch heart drug on its own

focus

knowledge

explore

explore